Featured in SCRS InSite Journal: Scott Gray, CEO, reflects on the impact COVID-19 had on the clinical trial industry, including the challenges faced and the swift response of the global healthcare community to ensure patient centricity.
Clinical Trial Patient Care in the COVID Era Read More »
Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs),
Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »
Providing Global Concierge Services to Facilitate Rare Disease Clinical Trial Participation and Retention
Empowered Patient Podcast with Karen Jagoda: Rare Disease Read More »
Featured in an article in PM360, Scott Gray, CEO, discusses new developments in the rare disease clinical trial industry ahead of the upcoming Rare Disease Day on February 28, 2022. Learn more about alleviating financial barriers to trial participation, mitigating geographical barriers to trial participation, and the federal efforts to support rare disease trials in
Enhancing Patient Access and Retention in Rare Disease Clinical Trials Read More »
Featured in CMSwire, Alexis Lynch, Senior Marketing Manager, discusses the techniques Clincierge utilizes to gain insight into patient feedback and preferences in clinical trials. Companies are increasingly relying on feedback from Voice of the Customer (VoC) programs to deliver better service, improve marketing efforts, improve customer loyalty and provide faster customer resolution. The article explores
4 Ways to Drive Better Voice of the Customer Feedback Read More »
Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations
Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »
In an article featured in BioProcess International, Scott Gray, CEO, discusses a practical approach to achieving inclusive representation in clinical studies. Life-science companies can attract large, diverse participant pools by reaching patients where they live, providing targeted and meaningful messaging about the benefits of trials and offering ongoing assistance.
A Practical Approach to Clinical Trial Diversity Read More »
In the Fall issue of Clinical Researcher, Scott Gray, CEO discusses how cross-border travel creates significant complexity for trial sponsors and clinical research organizations (CROs), who must contend with complicated travel logistics, participant and family unease, international regulatory compliance, and more. Although many of these challenges have been brought to light in recent years, COVID-19-era travel restrictions have only exacerbated these issues.
Overcoming the Logistics Challenges of Global Studies Read More »
Trial sponsors and clinical research organizations (CROs) face unique challenges when recruiting and maintaining participation in clinical trials. Even greater obstacles exist in trials requiring cross-border travel to participate.
Coordinating Cross-Border Travel to Support Clinical Trials Read More »
In the Fall issue of the Patients as Partners Newsletter, Scott Gray, CEO discusses the key benefits of engaging patients to improve diversity in clinical trials. When clinical trial stakeholders engage patients they can overcome barriers to participation and alleviate patient uncertainty which improves patients’ experiences and increases retention.
Patient Engagement: The Key to Improving Diversity in Clinical Trials Read More »
